Tim LaBua Photo

Industry Experience

Clinical Contracts and Finance Associate

Gilead Sciences, Inc.

Contracts Associate

Genentech, Inc.

Contracts Specialist

Impax Laboratories, Inc.

Tim is highly adept at counseling emerging growth life science companies in connection with a variety of financing and strategic partnership challenges, as well as merger and acquisition transactions. He also has extensive experience representing publicly-traded companies and helping business development teams navigate the complexities of early-stage strategic investments and purchase options.

experience +

experience –

Skadden, Arps, Slate, Meagher & Flom LLP

Associate Attorney

Wilmer Cutler Pickering Hale & Dorr LLP

Associate Attorney

  • Investment & Operations Counsel at prominent value-focused hedge fund

Recent Client Work +

Recent Client WOrk –

  • GV in its purchase of preferred equity in Endcadia, Inc.
  • Apic Bio, Inc. in its Series A Financing
  • XyloCor Therapeutics, Inc. in its Series A Financing
  • Venn Biosciences Corporation in its Series A Financing
  • Guardian Therapeutics, LLC in its acquisition of Band Therapeutics, LLC
  • Kantum Diagnostics, Inc. in its convertible debt financing
  • Synedgen, Inc. in its out-license of IP and sale of assets to Synspira, LLC
  • Synspira, LLC in its equity/debt financing and research funding from The Cystic Fibrosis Foundation Trust
  • Profit Tools, Inc. in its sale of certain assets to Valsoft Corporation
  • FOG Pharmaceuticals, Inc. in its Series B Financing
  • LifeMine Therapeutics, Inc. in its Series A Financing
  • Renoviso, Inc. in its Series A-1 Financing
  • Lundbeckfond Ventures in its sale of certain royalty rights
  • Bio-Pharm, Inc. in its acquisition by Torrent Pharmaceuticals Ltd.
  • Hexcel Corporation in its acquisition of the aerospace and defense business of Oxford Performance Materials, Inc.
  • Alnylam Pharmaceuticals, Inc. in its strategic collaboration with Vir Biotechnology to develop RNAi therapeutics for infectious diseases
  • .406 Ventures, LLC in its purchase of preferred equity in Trilio Data, Inc.
  • .406 Ventures, LLC as selling shareholder in the acquisition of Jisto, Inc. by Trilio Data, Inc.
  • VivoPharm Pty. Ltd. in its acquisition by Cancer Genetics, Inc.
  • GO Therapeutics, Inc. in its Series A-1 Financing
  • Lysosomal Therapeutics, Inc. in its exclusive option arrangement with Allergan plc
  • PTC Therapeutics, Inc. in its Senior Secured Term Loan Facility
  • Hexcel Corporation in its strategic investment in Carbon Conversions, Inc.

Community +

Community –

Joe is or has been involved in a wide range of philanthropic and community organizations, including:

  • The Center for Discovery. Pro bono counsel for R&D initiatives at a leading provider of medical and clinical care and education services for people with complex developmental disabilities.
  • Dana-Farber Cancer Institute and Partners in Health. Pro bono counsel for an international health services joint venture.
  • Center for Maine Contemporary Art, Board of DirectorsTrustees.
  • Partners Healthcare Center for Personalized Genetic Medicine, Genetics Advisory Council, past member.
  • Columbia University’s College of Physicians and Surgeons, Medical Science and Technology Council, past member.
  • CAVU Foundation, Board of Directors, past member. CAVU  supported community programs that enhance the health care of underserved children in Massachusetts.
  • Venturing Out, Board of Directors, past member. Venturing Out was an innovative not-for-profit organization that taught entrepreneurship to incarcerated and court-involved adults and high-risk youth.
  • The Possible Project, Co-Founder of a not-for-profit that helps young people imagine, create and run their own business.
  • Slow Money, Maine and New York chapters. Joe worked with leadership to create pathways for individuals and families to provide financial assistance to farmers and agriculture businesses promoting sustainable local food systems. He also developed novel “patient loan” structures that have been used to raise critical financing for businesses that are re-building agricultural and fisheries food infrastructures.

Joe has spoken on business law and ethics at the Massachusetts Institute of Technology (Program of Health Sciences and Technology), Ross School of Business at the University of Michigan (Net Impact Conference), and Boston College Law School.

Joe was a member of the National Finance Council and actively involved in the voter protection team for the Stacey Abrams for Governor campaign.

Bar Admissions
  • Massachusetts
Education
  • University of Michigan Law School, Dean's Scholarship
  • Brown University, B.A.